1.29 USD
-0.07 (-5.15%)
1.2899 USD
0 (-0.01%)
ChartMill assigns a Buy % Consensus number of 51% to AKYA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.45. This target is 12.08% above the current price.
AKYA was analyzed by 11 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about AKYA.
In the previous month the buy percentage consensus was at a similar level.
AKYA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-19 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-04-29 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-04-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-03-25 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2025-03-18 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-11-19 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-11-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-15 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-06 | BTIG | Downgrade | Buy -> Neutral |
| 2024-08-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-08-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-08-06 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-06-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-05-14 | BTIG | Maintains | Buy -> Buy |
| 2024-05-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-05 | UBS | Maintains | Buy -> Buy |
| 2024-03-05 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-12-14 | Guggenheim | Initiate | Neutral |
| 2023-11-13 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2023-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-12 | UBS | Maintains | Buy -> Buy |
| 2023-08-08 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-08-08 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-03-21 | Stephens & Co. | Reiterate | Overweight |
| 2023-03-08 | Morgan Stanley | Maintains | Overweight |
AKOYA BIOSCIENCES INC / AKYA FAQ
What do analysts expect the price target to be for AKOYA BIOSCIENCES INC (AKYA)?
11 analysts have analysed AKYA and the average price target is 1.45 USD. This implies a price increase of 12.08% is expected in the next year compared to the current price of 1.29.
Can you provide the consensus rating for AKOYA BIOSCIENCES INC stock?
The consensus rating for AKOYA BIOSCIENCES INC (AKYA) is 50.9091 / 100 . This indicates that analysts generally have a neutral outlook on the stock.